Press Releases

Conversion Shares Also Subject To 18-Month Lock-Up Agreement BETHESDA, MD, July 31, 2013 — Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today an agreement with the contract manufacturer of its vaccine, Cognate BioServices, Inc. (Cognate), to convert the $11.6 million of accounts payable to Cognate into shares of NW... Read More

MD Anderson Is The First Site; Other Sites In The US And UK To Follow BETHESDA, MD, June 13, 2013 — Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that its 60-patient Phase I/II clinical trial of DCVax-Direct for all inoperable solid tumor cancers has been initiated at The University of Texas MD Anderson Cancer... Read More

To Review Products For Both Operable and Inoperable Brain Tumors BETHESDA, Md., June 6, 2013 — Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, today announced that its Chief Technical Officer, Dr. Marnix Bosch, will make a presentation at the Brain Tumor Biotech Summit sponsored by the Weill Cornell Medical College and Voices... Read More

Recognition To Enhance Immune Therapy Visibility In Global Financial Markets BETHESDA, Md., June 3, 2013 — Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that NW Bio was added to the MSCI Global MicroCap Index as of the close of the stock market on Friday, May 31, 2013. MSCI Inc. is a leading provider of... Read More

BETHESDA, Md., May 28, 2013 — Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that Linda F. Powers, the Company’s Chairman and Chief Executive Officer, will be presenting at the Marcum MicroCap Conference at 3:00 pm EDT on Thursday, May 30, 2013, in the Estate 4 Room at the Grand Hyatt Hotel in New York, New... Read More